While Radnet Inc has underperformed by -2.18%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RDNT rose by 7.48%, with highs and lows ranging from $93.65 to $45.82, whereas the simple moving average fell by -22.32% in the last 200 days.
On March 05, 2025, Raymond James Upgraded Radnet Inc (NASDAQ: RDNT) to Strong Buy. A report published by Barclays on September 06, 2024, Upgraded its rating to ‘Overweight’ for RDNT. Barclays also rated RDNT shares as ‘Equal Weight’, setting a target price of $48 on the company’s shares in an initiating report dated March 06, 2024. Truist Initiated an Buy rating on August 31, 2023, and assigned a price target of $40. CJS Securities initiated its ‘Market Outperform’ rating for RDNT, as published in its report on March 31, 2023. Raymond James’s report from March 03, 2023 suggests a price prediction of $30 for RDNT shares, giving the stock a ‘Outperform’ rating. Barclays also rated the stock as ‘Overweight’.
Analysis of Radnet Inc (RDNT)
Further, the quarter-over-quarter increase in sales is 13.49%, showing a positive trend in the upcoming months.
One of the most important indicators of Radnet Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 0.36% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.12, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and RDNT is recording 889.70K average volume. On a monthly basis, the volatility of the stock is set at 6.39%, whereas on a weekly basis, it is put at 5.36%, with a gain of 4.64% over the past seven days. Furthermore, long-term investors anticipate a median target price of $75.33, showing growth from the present price of $50.70, which can serve as yet another indication of whether RDNT is worth investing in or should be passed over.
How Do You Analyze Radnet Inc Shares?
The Diagnostics & Research market is dominated by Radnet Inc (RDNT) based in the USA. When comparing Radnet Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 1550.46, there is a growth in quarterly earnings of 358.39%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 10.82%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 87.40% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
RDNT shares are owned by institutional investors to the tune of 87.40% at present.
